Company Revenue

The company grew 11.1% on a pro forma basis in 1Q23, driven by strength across its businesses and no major...

The company grew more than 30% in the first quarter of 2023 despite ongoing staffing challenges at pediatric hospitals....

The company grew 20% in 1Q23 due to improving procedure volumes, competitive rep recruiting and robotic pull-through....

The company's 1Q23 sales declined in the high teens as its business model shift and operational challenges take a toll....

The company grew in the high teens in 1Q23 due to easing market pressures in the U.S. and some international...

The company grew 54% in 1Q23 and acquired the REMI navigated robotics system as ATEC prepares for the modernization of...

The company grew in the low double-digits for 1Q23, driven by easier comps from the prior year, easing market pressure...

The company's spine business declined in the high-single-digits in 1Q23 but will benefit from more commercial focus in 2023....

SI-BONE reported 1Q23 orthopedic sales of $32.7 million, +45.8% compared to the first quarter of 2021. A stabilizing macro environment, robust...

The company grew in the low double-digits due to improving procedure volumes and continued sales force execution....